Source comparison
Melanotan-2 Degradation Reconstituted: Stability Comparison
Understanding how storage and handling variables impact melanotan-2 degradation reconstituted requires comparing degradation rates under different conditions. The table below summarises stability data based on published peptide stability studies and Real Pepti
This comparison does not assign a generated winner or score.
- Understanding how storage and handling variables impact melanotan-2 degradation reconstituted requires comparing degradation rates under different conditions. The table below summarises stability data based on published peptide stability studies and Real Peptides' internal handling protocols.
- Refrigerated, dark storage
- 2–8°C
- Minimal (amber vial or foil-wrapped)
- 85–90%
- Slow oxidation of Met residues
- Recommended standard. Maximises usable lifespan
- Refrigerated, ambient light
- Daily exposure during draws
- 65–75%
- Photooxidation of His + Met residues
- Common real-world scenario. Acceptable if vial used within 14 days
- Room temperature, dark
- 20–25°C
- Minimal
- 50–60%
- Accelerated oxidation + deamidation
- Avoid. Potency loss too rapid for most protocols
- Room temperature, ambient light
- Daily exposure
- 30–40%
- Combined photooxidation + thermal degradation
- Unacceptable. Peptide functionally inactivated
- Single freeze-thaw cycle
- −20°C then thawed
- N/A
- 20–40%
- Aggregation + structural disruption
- Irreversible damage. Discard vial
- Refrigerated with repeated air exposure
- 70–80%
- Cumulative oxidation from dissolved O₂
- Improved by using low-dead-space syringes
- The bottom line: melanotan-2 degradation reconstituted is manageable if you refrigerate immediately, protect from light, and use within 28 days. Any deviation from 2–8°C storage or exposure to freeze-thaw cycles results in potency loss that cannot be reversed. Researchers using Melanotan 2 MT2 10mg should implement these storage protocols from the moment reconstitution occurs.